Evidence map›Paper›PMID 42446383›Full record

ArticleThe Journal of antimicrobial chemotherapy2026

Genomic analyses of antibiotic-resistant Escherichia coli from extensive beef cattle and sheep farms identifies inter-species and farm-farm sharing as clonal dissemination pathways.

Noora Peltonen, Jordan E Sealey, Oliver Mounsey, Caroline M Best, Beatriz Llamazares, Will Miller, Yelyzaveta Moiseienko, Katie L Sealey, Elliot Stanton, Emily Syvret and 4 more

Abstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Noora PeltonenSchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Jordan E SealeySchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Oliver MounseySchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Caroline M BestBristol Veterinary School, University of Bristol, Langford House, Langford, Bristol BS40 5DU, UK.
Beatriz LlamazaresSchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Will MillerSchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Yelyzaveta MoiseienkoSchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Katie L SealeySchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Elliot StantonBristol Veterinary School, University of Bristol, Langford House, Langford, Bristol BS40 5DU, UK.
Emily SyvretSchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Lucy VassBristol Veterinary School, University of Bristol, Langford House, Langford, Bristol BS40 5DU, UK.
Laura WrightSchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Kristen K ReyherBristol Veterinary School, University of Bristol, Langford House, Langford, Bristol BS40 5DU, UK.ORCID 0000-0003-4912-5026
Matthew B AvisonSchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.ORCID 0000-0003-1454-8440

Funding

Biotechnology and Biological Sciences Research CouncilEuropean UnionWelsh Government BB/T008741/1Welsh Government BB/X012670/1Welsh Government C003/2023/2024Welsh Government Rural Communities
6 · The paper itself

Abstract

backgroundGlobally, there is a large gap in our understanding of the prevalence, ecology and transmission dynamics of antibiotic resistance (ABR) in extensively reared ruminants, despite these animals contributing to the food chain and frequently sharing land with humans.

methodsFive hundred and seventy-one visits to 33 Welsh beef cattle and/or sheep farms resulted in 1874 samples being collected at faecally contaminated sites from April 2022 to March 2023 (ADGC1) and September 2023 to December 2024 (ADGC2). Samples were tested for resistant Escherichia coli using amoxicillin, streptomycin, spectinomycin, cefotaxime and ciprofloxacin. WGS used Illumina technology. Clonal relationships were determined following core-genome alignment.

resultsA significant reduction in positivity for spectinomycin-resistant E. coli in sheep samples from ADGC1 to ADGC2 was observed, coincident with market withdrawal of a spectinomycin-containing preparation widely used in sheep. Reductions were seen in 19/22 sheep flocks with nine seeing a >50% reduction. Resistance to other tested antibiotics was unchanged. Phenotypic analysis and WGS for 713 E. coli showed that resistance to antibacterials important for human medicine was rare and genetically diverse. We identified 77 E. coli clones (<100 SNP cutoff) circulating among study farms with mixed farms contributing most; clones were also shared between animal species on mixed farms.

conclusionsFor extensively reared ruminants, ABR-reducing efforts can have significant impacts on ABR on farms. Focusing these efforts onto farms contributing to the most animal movement and mixing events may generate the greatest reductions in overall on-farm ABR prevalence at regional and national levels.

Indexed as

Anti-Bacterial AgentsCattle DiseasesDrug Resistance, BacterialDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsSheep DiseasesAnimalsCattleFarmsFecesGenome, BacterialGenomicsMicrobial Sensitivity TestsSheepWhole Genome SequencingAnti-Bacterial Agents

Identifiers

PMID42446383
PMCPMC13366539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.